Cargando…

Antimutagenic compounds and their possible mechanisms of action

Mutagenicity refers to the induction of permanent changes in the DNA sequence of an organism, which may result in a heritable change in the characteristics of living systems. Antimutagenic agents are able to counteract the effects of mutagens. This group of agents includes both natural and synthetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Słoczyńska, Karolina, Powroźnik, Beata, Pękala, Elżbieta, Waszkielewicz, Anna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990861/
https://www.ncbi.nlm.nih.gov/pubmed/24615570
http://dx.doi.org/10.1007/s13353-014-0198-9
_version_ 1782312348788195328
author Słoczyńska, Karolina
Powroźnik, Beata
Pękala, Elżbieta
Waszkielewicz, Anna M.
author_facet Słoczyńska, Karolina
Powroźnik, Beata
Pękala, Elżbieta
Waszkielewicz, Anna M.
author_sort Słoczyńska, Karolina
collection PubMed
description Mutagenicity refers to the induction of permanent changes in the DNA sequence of an organism, which may result in a heritable change in the characteristics of living systems. Antimutagenic agents are able to counteract the effects of mutagens. This group of agents includes both natural and synthetic compounds. Based on their mechanism of action among antimutagens, several classes of compounds may be distinguished. These are compounds with antioxidant activity; compounds that inhibit the activation of mutagens; blocking agents; as well as compounds characterized with several modes of action. It was reported previously that several antitumor compounds act through the antimutagenic mechanism. Hence, searching for antimutagenic compounds represents a rapidly expanding field of cancer research. It may be observed that, in recent years, many publications were focused on the screening of both natural and synthetic compounds for their beneficial muta/antimutagenicity profile. Thus, the present review attempts to give a brief outline on substances presenting antimutagenic potency and their possible mechanism of action. Additionally, in the present paper, a screening strategy for mutagenicity testing was presented and the characteristics of the most widely used antimutagenicity assays were described.
format Online
Article
Text
id pubmed-3990861
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-39908612014-04-22 Antimutagenic compounds and their possible mechanisms of action Słoczyńska, Karolina Powroźnik, Beata Pękala, Elżbieta Waszkielewicz, Anna M. J Appl Genet Microbial Genetics · Review Mutagenicity refers to the induction of permanent changes in the DNA sequence of an organism, which may result in a heritable change in the characteristics of living systems. Antimutagenic agents are able to counteract the effects of mutagens. This group of agents includes both natural and synthetic compounds. Based on their mechanism of action among antimutagens, several classes of compounds may be distinguished. These are compounds with antioxidant activity; compounds that inhibit the activation of mutagens; blocking agents; as well as compounds characterized with several modes of action. It was reported previously that several antitumor compounds act through the antimutagenic mechanism. Hence, searching for antimutagenic compounds represents a rapidly expanding field of cancer research. It may be observed that, in recent years, many publications were focused on the screening of both natural and synthetic compounds for their beneficial muta/antimutagenicity profile. Thus, the present review attempts to give a brief outline on substances presenting antimutagenic potency and their possible mechanism of action. Additionally, in the present paper, a screening strategy for mutagenicity testing was presented and the characteristics of the most widely used antimutagenicity assays were described. Springer Berlin Heidelberg 2014-03-11 2014 /pmc/articles/PMC3990861/ /pubmed/24615570 http://dx.doi.org/10.1007/s13353-014-0198-9 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/2.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Microbial Genetics · Review
Słoczyńska, Karolina
Powroźnik, Beata
Pękala, Elżbieta
Waszkielewicz, Anna M.
Antimutagenic compounds and their possible mechanisms of action
title Antimutagenic compounds and their possible mechanisms of action
title_full Antimutagenic compounds and their possible mechanisms of action
title_fullStr Antimutagenic compounds and their possible mechanisms of action
title_full_unstemmed Antimutagenic compounds and their possible mechanisms of action
title_short Antimutagenic compounds and their possible mechanisms of action
title_sort antimutagenic compounds and their possible mechanisms of action
topic Microbial Genetics · Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990861/
https://www.ncbi.nlm.nih.gov/pubmed/24615570
http://dx.doi.org/10.1007/s13353-014-0198-9
work_keys_str_mv AT słoczynskakarolina antimutageniccompoundsandtheirpossiblemechanismsofaction
AT powroznikbeata antimutageniccompoundsandtheirpossiblemechanismsofaction
AT pekalaelzbieta antimutageniccompoundsandtheirpossiblemechanismsofaction
AT waszkielewiczannam antimutageniccompoundsandtheirpossiblemechanismsofaction